BRPI1008384A2 - composição que compreende n2-(1-oxohexadecil)-lisil-valil-lisina para tratamento de rosácea e seus sintomas - Google Patents

composição que compreende n2-(1-oxohexadecil)-lisil-valil-lisina para tratamento de rosácea e seus sintomas

Info

Publication number
BRPI1008384A2
BRPI1008384A2 BRPI1008384A BRPI1008384A BRPI1008384A2 BR PI1008384 A2 BRPI1008384 A2 BR PI1008384A2 BR PI1008384 A BRPI1008384 A BR PI1008384A BR PI1008384 A BRPI1008384 A BR PI1008384A BR PI1008384 A2 BRPI1008384 A2 BR PI1008384A2
Authority
BR
Brazil
Prior art keywords
oxohexadecyl
lysyl
symptoms
composition
treating rosacea
Prior art date
Application number
BRPI1008384A
Other languages
English (en)
Inventor
Imfeld Dominik
moser Heidi
Hochegger Leo
Gempler Mathias
Graeub Remo
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of BRPI1008384A2 publication Critical patent/BRPI1008384A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
BRPI1008384A 2009-02-20 2010-02-16 composição que compreende n2-(1-oxohexadecil)-lisil-valil-lisina para tratamento de rosácea e seus sintomas BRPI1008384A2 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20234209P 2009-02-20 2009-02-20
US20234109P 2009-02-20 2009-02-20
EP09153271 2009-02-20
EP09153270 2009-02-20
PCT/EP2010/000943 WO2010094452A2 (en) 2009-02-20 2010-02-16 Novel composition

Publications (1)

Publication Number Publication Date
BRPI1008384A2 true BRPI1008384A2 (pt) 2017-02-21

Family

ID=42359515

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1008384A BRPI1008384A2 (pt) 2009-02-20 2010-02-16 composição que compreende n2-(1-oxohexadecil)-lisil-valil-lisina para tratamento de rosácea e seus sintomas

Country Status (7)

Country Link
US (1) US20120064020A1 (pt)
EP (1) EP2398489A2 (pt)
JP (1) JP2012518606A (pt)
KR (1) KR20110130434A (pt)
CN (1) CN102325543A (pt)
BR (1) BRPI1008384A2 (pt)
WO (1) WO2010094452A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2387438B1 (es) * 2011-03-01 2013-07-31 Luz Divina Fuentes Garcia Composición de una crema para el tratamiento de la piel
BR112015015123A2 (pt) * 2012-12-24 2017-07-11 Unilever Nv composição cosmética, método para aprimoramento da característica de pele e uso de uma composição
JPWO2016121867A1 (ja) * 2015-01-28 2017-11-02 国立大学法人九州大学 脂質ペプチド型化合物を含有する経皮吸収基材
US10561702B2 (en) * 2015-12-16 2020-02-18 Dsm Ip Assets B.V. Method for the treatment of skin disorders using dipeptide diaminobutyroyl benzylamide diacetate
KR101681568B1 (ko) * 2016-03-11 2016-12-01 박미승 해조류 추출물을 포함하는 제모용 왁스 조성물 및 그 제조 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3712986A1 (de) * 1987-04-16 1988-10-27 Marbert Gmbh Medizinische zubereitungen auf der grundlage von biertreberextrakt, verfahren zu deren herstellung sowie verwendung von biertreberextrakt zur herstellung von kosmetischen zubereitungen und ein spezieller biertreberextrakt
US6296861B1 (en) * 1999-05-03 2001-10-02 Nicholas V. Perricone Treatment of skin damage using conjugated linoleic acid and ascorbyl fatty acid esters
ES2280962T3 (es) * 2003-05-08 2007-09-16 Pentapharm Ag Tripeptidos y derivados de los mismos para aplicaciones cosmeticas para la estructura de la piel.
EP1640041A3 (de) * 2004-09-24 2006-05-24 Henkel Kommanditgesellschaft auf Aktien Kosmetische und dermatologische Zusammensetzungen zur Behandlung reifer oder lichtgeschädigter Haut

Also Published As

Publication number Publication date
EP2398489A2 (en) 2011-12-28
WO2010094452A3 (en) 2010-10-14
CN102325543A (zh) 2012-01-18
US20120064020A1 (en) 2012-03-15
JP2012518606A (ja) 2012-08-16
WO2010094452A2 (en) 2010-08-26
KR20110130434A (ko) 2011-12-05

Similar Documents

Publication Publication Date Title
BRPI0908503A2 (pt) partícula com um diâmetro menor que 2mm, e, composição para o tratamento de tecidos
BRPI0815353A2 (pt) Compoições e dhea para o tratamento da menopausa
BRPI0821496A2 (pt) Composições nanopartículas que proporcionam aprimorada coloração para formulações cosméticas
BRPI0922296A2 (pt) Composições para o uso em recém-nascidos com baixo peso no nascimento.
BRPI0907162A2 (pt) Composto, composição farmacêutica e métodos para ativar procaspase executora 3, 6 e/ou 7 e para tratar um estado de doença em um mamífero
BRPI1011572A2 (pt) Glico-oligossacarídeos compreendendo ligações glicosídias (alfa1-4) e (alfa1-6), seu uso, e métodos para o seu fornecimento
CL2011001966A1 (es) Composicion farmaceutica que comprende derivados de glucopiranosil difenilmetano como inhibidor sglt-2; forma farmaceutica que comprende una composicion farmaceutica; procedimiento de preparacion y uso en el control glucemico.
BRPI0909639A2 (pt) Barra de carboidrato e uso da mesma
CL2011001254A1 (es) Combinacion farmaceutica que comprende un anticuerpo que reconoce especificamente a cd38 y al menos melfalan; y su uso para el tratamiento contra el cancer.
BRPI0924427A2 (pt) composição farmacêutica de liberação controlada, seu processo de preparação e uso da mesma
BRPI0914319A2 (pt) anticorpos estáveis e solúveis que inibem tnfalfa
BRPI0917330A2 (pt) aprefeiçoamento dinamico para apresentações de conteúdo
CL2013001410A1 (es) Variante polipeptidica de fgf21; multimero que la comprende; composicion farmaceutica que la comprende; y su uso para tratar uno o mas trastornos asociados a fgf21.
CL2007002682A1 (es) Compuestos derivados de 4-metilpiridopirimidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar el crecimiento anormal de celulas, como cancer.
BRPI0921317A2 (pt) composto, composição farmacêutica, e, método para tratar ou prevenir uma patologia relacionada com abeta em um mamífero
CL2013001433A1 (es) Composicion que comprende al menos una n-acetil lactosamina, al menos un oligosacarido sialilado al menos un oligosacarido fucosilado; y su uso en la prevencion de infecciones respiratorias agudas y/o para aliviar los sintomas de dichas infecciones.
BRPI0910459A2 (pt) agentes nucleares para polihidroxialcanoatos
BRPI1015547A2 (pt) aparelho utilizável com um poço, válvula de retenção utilizável em um poço, e disposição de válvula de retenção útil em um poço.
BRPI0920121A2 (pt) conjugados de etoposida e doxorubicina para liberação de fármaco
BRPI1013503A2 (pt) formulação de iniciador não cromado que inibe corrosão, e, estrutura
DE112009002540A5 (de) Berührungslose Hebelvorrichtung
BRPI0823288A2 (pt) Caixa para embalagem, e, matriz de caixa para embalagem
BRPI0911186A2 (pt) trem de rolamento unitário e conjunto de rolamento que o compreende
BRPI0908493A2 (pt) composições compreendendo fitoestrogênicos seletivos para receptor de estrogênio beta e fibras alimentares
BRPI0919794A2 (pt) dispositivo para uso intracorpóreo, e, composto

Legal Events

Date Code Title Description
B15I Others concerning applications: loss of priority
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]